Sources

10 Total Sources

AbbVie Buys Apogee for $10.9 Billion to Deepen Immunology Pipeline

AbbVie to Acquire Apogee Therapeutics for $10.9 Billion, Deepening Immunology Portfolio

Finimize17h ago

AbbVie Nears $10.9 Billion Deal For Apogee Therapeutics - Finimize

Yahoo Finance17h ago

AbbVie strikes $10.9 billion deal for Apogee Therapeutics

pharmaphorum17h ago

AbbVie climbs post-Allergan M&A peak with Apogee buy | pharmaphorum

Yahoo Finance17h ago

AbbVie's biggest deal since 2019 could land soon

AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio " AbbVie (NYSE: $ABBV) and Apogee Therapeutics (NASDAQ: $APGE) ("Apogee") today announced they have entered into a definitive agreement under which AbbVie will acquire Apogee

AbbVie to Acquire Apogee Therapeutics in $10.9 Billion Immunology Deal | citybiz

streamlinefeed.co.ke5h ago

AbbVie Buys Apogee for $10.9 Billion to Acquire Inflammatory Disease Drug Pipeline | Streamline

Marketscreener.com17h ago

AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio | MarketScreener

advfn.com17h ago

APGE - AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio